Title
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Reference number
cb-93-39360034
Solicitation number
1000273405
Publication date
2026-08-20
Tender closing date
2026-09-18T12:00:00
Unspsc description
*Drugs and Pharmaceutical Products
Notice type
Request for Proposal
Procurement method
Competitive - Open bidding
Selection criteria
Highest Combined Rating of Technical Merit and Price
Trade agreements
*Canada-Colombia Free Trade Agreement
*Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
*Canada-Peru Free Trade Agreement (CPFTA)
*Canada-Panama Free Trade Agreement
*Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
*Canada-UK Trade Continuity Agreement (Canada-UK TCA)
*World Trade Organization Agreement on Government Procurement (WTO GPA)
*Canada-Honduras Free Trade Agreement
*North American Free Trade Agreement (NAFTA)
*Canada-Chile Free Trade Agreement (CCFTA)
*Canada-Ukraine Free Trade Agreement (CUFTA)
*Canada-Korea Free Trade Agreement (CKFTA)
*Canadian Free Trade Agreement (CFTA)
Regions of opportunity
*Canada
Regions of delivery
*National Capital Region (NCR)
Contracting entity name
Department of Health (HC)
Contracting entity address line
200 Eglantine Driveway
Contracting entity address city
Ottawa
Contracting entity address province
Ontario
Contracting entity address postal code
K1A 0K9
Contracting entity address country
Canada
Contact info name
S•••••• D•••
Contact info email
s••••••••@•••••.••.ca
Contact info phone
000••••••
Contact info fax
000••••••
Contact info address line
••• •••••••• ••••••••
Contact info province
•••••••• ••••••• •••••• (•••)
Contact info postalcode
••••••
Contact info country
••••••
Attachment
https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/english-rfp-1000273405-final.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/qs-as-2.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/appendix-b---sow-stream-2-final.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/appendix-a---sow-stream-1-final.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/annexe-c---edt-flux-3-final.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/appendix-c---sow-stream-3-final.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/qs-as-1.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/appendix-a---sow-stream-1-amended-20260901.pdf,https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/104310/appendix-b---sow-stream-2-amendment-1.pdf
Tender description
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2
Amendment 2 - Questions & Answers #2 and Amendment to Annex A - SOW Stream 1
Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments.
The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of three categories of emerging drugs: novel synthetic opioids, synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the Office of Legislative and Regulatory Affairs (OLRA) to make more informed regulatory science decisions.
For all three streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports.
Canada is seeking offers from Offerors to provide Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids in three (3) separate streams to Health Canada. Stream 1 - In vitro pharmacological testing of emerging opioids at the Mu Opioid Receptor (MOR). Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream, two (2) streams or all three (3) streams. Up to three (3) contracts may be awarded under this request for proposal.
